A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial

Background. West Nile virus (WNV) is a flavivirus that causes meningitis and encephalitis. There are no licensed vaccines to prevent WNV in humans. The safety and immunogenicity of a first-generation WNV DNA vaccine was demonstrated in a clinical trial and a similar DNA vaccine has been licensed for...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ledgerwood, Julie E., Pierson, Theodore C., Hubka, Sarah A., Desai, Niraj, Rucker, Steve, Gordon, Ingelise J., Enama, Mary E., Nelson, Steevenson, Nason, Martha, Gu, Wenjuan, Bundrant, Nikkida, Koup, Richard A., Bailer, Robert T., Mascola, John R., Nabel, Gary J., Graham, Barney S.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2011
Témata:
Major Articles and Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3080891/
https://ncbi.nlm.nih.gov/pubmed/21398392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jir054
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky